4.7 Article

Functional evaluation of the tachycardia patient-derived iPSC cardiomyocytes carrying a novel pathogenic SCN5A variant

期刊

JOURNAL OF CELLULAR PHYSIOLOGY
卷 237, 期 10, 页码 3900-3911

出版社

WILEY
DOI: 10.1002/jcp.30843

关键词

cardiovascular diseases; in vitro disease model; iPSC; SCN5A variant; tachycardia

资金

  1. Scientific and Technological Research Council of Turkey (TUBITAK) [213S192]

向作者/读者索取更多资源

This study investigated the influence of an SCN5A gene variant on tachycardia phenotype by analyzing patient-specific iPSCs and cardiomyocytes. The findings revealed a novel pathogenic SCN5A variant associated with altered Na+ channel kinetics, potentially leading to high excitability and tachycardia phenotype. The patient-derived iPSC-CM model recapitulated clinically relevant characteristics of tachycardia, offering insight into the underlying mechanisms.
Tachycardia is characterized by high beating rates that can lead to life-threatening fibrillations. Mutations in several ion-channel genes were implicated with tachycardia; however, the complex genetic contributors and their modes of action are still unclear. Here, we investigated the influence of an SCN5A gene variant on tachycardia phenotype by deriving patient-specific iPSCs and cardiomyocytes (iPSC-CM). Two tachycardia patients were genetically analyzed and revealed to inherit a heterozygous p.F1465L variant in the SCN5A gene. Gene expression and immunocytochemical analysis in iPSC-CMs generated from patients did not show any significant changes in mRNA levels of SCN5A or gross NaV1.5 cellular mislocalization, compared to healthy-derived iPSC-CMs. Electrophysiological and contraction imaging analysis in patient iPSC-CMs revealed intermittent fibrillation-like states, occasional arrhythmic events, and sustained high-paced contractions that could be selectively reduced by flecainide treatment. The patch-clamp analysis demonstrated a negative shift in the voltage-dependent activation at the patient-derived iPSC-CMs compared to the healthy control line, suggestive of a gain-of-function activity associated with the SCN5A(+/p.F1465L) variant. Our patient-derived iPSC-CM model recapitulated the clinically relevant characteristics of tachycardia associated with a novel pathogenic SCN5A(+/p.F1465L) variant leading to altered Na+ channel kinetics as the likely mechanism underlying high excitability and tachycardia phenotype.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据